← Leaderboards
Mohammad Badran
University Of Missouri-Columbia
$1,880,847
Attributed
$1,880,847
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $675K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,880,847 · 1
By mechanism
R01$1,880,847 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Meredith Hay$10,722,587
- David Douglas Kline$9,120,421
- Guanghong Jia$2,443,189
- Michael John Davis$16,293,344
- M Harold Laughlin$11,817,849
Others in their field
Other Rising Stars on “Adjuvant Therapy”
- Robert W Cross · University Of Texas Med Br Galveston$4,640,498
- Jeff P Simko · Washington University$4,624,354
- Kathryn Marie Jones · Baylor College Of Medicine$3,103,804
- Amy Fowler · University Of Wisconsin-Madison$3,008,001
- Alice Chia- Chi Wei · Sloan-Kettering Inst Can Research$2,617,533
- Hua Wang · University Of Illinois At Urbana-Champaign$2,593,656
Research focus
Adjuvant TherapyAldosteroneAnimalsAntagonistAreaAtherosclerosisBloodBlood PressureBlood Pressure ReductionBlood VesselsCardiacCardiovascular DiseasesCardiovascular Risk FactorCardiovascular SystemCellsChronicClinically SignificantClinical TrialsCollagen FiberContinuous Positive Airway PressureCoronaryCoronary ArteryCoronary Heart DiseaseAcceleration
Grant awards (3)
Coronary artery dysfunction in OSA: Role of mineralocorticoid receptors$598,360
R01 · FY2025 · HL · contact PI
Coronary artery dysfunction in OSA: Role of mineralocorticoid receptors$607,475
R01 · FY2024 · HL · contact PI
Coronary artery dysfunction in OSA: Role of mineralocorticoid receptors$675,012
R01 · FY2023 · HL · contact PI